Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects

Victor M. Luna(James A. Haley Veterans' Hospital), Robert V. Farese(University of South Florida)

Diabetologia

January 4, 2006

10.1007/s00125-005-0112-4

Cited by 50

Related Papers

Activation of Protein Kinase C-ζ by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose Tolerance

|Diabetes|2003|162

Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes

|Journal of Clinical Investigation|2007|162

Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1–40/42 and Phospho-Tau May Abet Alzheimer Development

|Diabetes|2016|84

Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance

|Diabetologia|2009|58

Requirements for Pseudosubstrate Arginine Residues during Autoinhibition and Phosphatidylinositol 3,4,5-(PO4)3-dependent Activation of Atypical PKC

|Journal of Biological Chemistry|2014|28